CY1111878T1 - Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερoy πεπτικου σωληνα - Google Patents

Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερoy πεπτικου σωληνα

Info

Publication number
CY1111878T1
CY1111878T1 CY20111100274T CY111100274T CY1111878T1 CY 1111878 T1 CY1111878 T1 CY 1111878T1 CY 20111100274 T CY20111100274 T CY 20111100274T CY 111100274 T CY111100274 T CY 111100274T CY 1111878 T1 CY1111878 T1 CY 1111878T1
Authority
CY
Cyprus
Prior art keywords
treatment
pharmaceutical preparation
upper dental
dental tube
tube
Prior art date
Application number
CY20111100274T
Other languages
Greek (el)
English (en)
Inventor
Markus Dr Pröls
Rudolf Dr Wilhelm
Original Assignee
Dr. Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39951664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1111878(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dr. Falk Pharma Gmbh filed Critical Dr. Falk Pharma Gmbh
Publication of CY1111878T1 publication Critical patent/CY1111878T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
CY20111100274T 2008-07-21 2011-03-11 Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερoy πεπτικου σωληνα CY1111878T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08013091A EP2151235B1 (de) 2008-07-21 2008-07-21 Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes

Publications (1)

Publication Number Publication Date
CY1111878T1 true CY1111878T1 (el) 2015-11-04

Family

ID=39951664

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20111100274T CY1111878T1 (el) 2008-07-21 2011-03-11 Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερoy πεπτικου σωληνα
CY20131100174T CY1113719T1 (el) 2008-07-21 2013-02-26 Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερου πεπτικου σωληνα

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20131100174T CY1113719T1 (el) 2008-07-21 2013-02-26 Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερου πεπτικου σωληνα

Country Status (23)

Country Link
US (2) US8580300B2 (enExample)
EP (2) EP2151235B1 (enExample)
JP (2) JP5616889B2 (enExample)
CN (1) CN102159196B (enExample)
AT (1) ATE498396T1 (enExample)
AU (1) AU2009273361B2 (enExample)
CA (1) CA2731312C (enExample)
CY (2) CY1111878T1 (enExample)
DE (1) DE502008002621D1 (enExample)
DK (2) DK2151235T3 (enExample)
EA (1) EA018465B1 (enExample)
ES (2) ES2358158T3 (enExample)
HR (2) HRP20130171T1 (enExample)
IL (1) IL210779A (enExample)
ME (2) ME01256B (enExample)
NZ (1) NZ590593A (enExample)
PL (2) PL2151235T3 (enExample)
PT (2) PT2151235E (enExample)
RS (2) RS51649B (enExample)
SI (2) SI2151235T1 (enExample)
UA (1) UA100759C2 (enExample)
WO (1) WO2010009961A1 (enExample)
ZA (1) ZA201100283B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2000076478A1 (en) 1999-06-14 2000-12-21 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
PT2151235E (pt) * 2008-07-21 2011-03-21 Falk Pharma Gmbh Formulação farmacêutica para o tratamento do trato digestivo superior
CA2765033C (en) 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
CN106421797A (zh) 2009-10-01 2017-02-22 艾戴尔医药公司 口服给予的皮质类固醇组合物
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
PL2886108T5 (pl) 2013-12-23 2023-02-27 Dr. Falk Pharma Gmbh Zoptymalizowana formulacja farmaceutyczna do leczenia zmian zapalnych przełyku
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
WO2020084530A1 (en) 2018-10-24 2020-04-30 Ferring B.V. Mucoadhesive pharmaceutical compositions of corticosteroids

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332394A1 (de) 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
GB9611364D0 (en) * 1996-05-31 1996-08-07 Smithkline Beecham Plc Composition
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
JP3818789B2 (ja) * 1999-02-18 2006-09-06 三菱化学フーズ株式会社 易崩壊性錠剤
WO2003006629A1 (en) 2001-07-11 2003-01-23 Toshirou Sekine Culturing method and device for photosynthetic microbes
CA2461042A1 (en) * 2001-09-25 2003-04-03 Ashish Madan Process for the preparation of fast dissolving dosage form
WO2003043518A2 (en) * 2001-11-20 2003-05-30 Dmi Biosciences, Inc. Methods and products for oral care
JP2005526095A (ja) * 2002-03-20 2005-09-02 エラン ファーマ インターナショナル，リミティド 脆砕性の低い急速溶解投与剤型
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20060013873A1 (en) * 2004-07-16 2006-01-19 Chih-Chiang Yang Bioadhesive dosage form of steroids
US20070071817A1 (en) * 2005-09-26 2007-03-29 Phyzz, Inc. Effervescent oral care compositions and method of use
US20070191323A1 (en) * 2006-02-15 2007-08-16 Verus Pharmaceuticals, Inc. Stable corticosteroid mixtures
SI2170348T1 (sl) * 2007-06-22 2016-12-30 Dompe Farmaceutici S.P.A. Šumeče tablete za inhalacijsko uporabo
WO2009043844A2 (en) * 2007-10-01 2009-04-09 Laboratorios Lesvi, S.L. Orodispersible tablets
PT2151235E (pt) * 2008-07-21 2011-03-21 Falk Pharma Gmbh Formulação farmacêutica para o tratamento do trato digestivo superior
CA2765033C (en) * 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders

Also Published As

Publication number Publication date
HRP20130171T1 (hr) 2013-03-31
DE502008002621D1 (de) 2011-03-31
US8580300B2 (en) 2013-11-12
SI2151235T1 (sl) 2011-04-29
CN102159196B (zh) 2013-05-08
EP2151235B1 (de) 2011-02-16
ATE498396T1 (de) 2011-03-15
PT2151235E (pt) 2011-03-21
JP2011528679A (ja) 2011-11-24
JP2014221827A (ja) 2014-11-27
US20110123460A1 (en) 2011-05-26
EA018465B1 (ru) 2013-08-30
HK1149907A1 (en) 2011-10-21
EP2306988B1 (de) 2013-01-09
ME01256B (me) 2013-06-20
IL210779A0 (en) 2011-03-31
PT2306988E (pt) 2013-02-15
ES2358158T3 (es) 2011-05-06
NZ590593A (en) 2012-07-27
SI2306988T1 (sl) 2013-03-29
WO2010009961A1 (de) 2010-01-28
CA2731312C (en) 2016-05-10
ES2399321T3 (es) 2013-03-27
PL2151235T3 (pl) 2011-05-31
CY1113719T1 (el) 2016-06-22
HRP20110208T1 (hr) 2011-04-30
AU2009273361B2 (en) 2014-03-20
RS51649B (sr) 2011-10-31
JP6209495B2 (ja) 2017-10-04
PL2306988T3 (pl) 2013-04-30
DK2306988T3 (da) 2013-03-18
CA2731312A1 (en) 2010-01-28
CN102159196A (zh) 2011-08-17
RS52662B (sr) 2013-06-28
AU2009273361A1 (en) 2010-01-28
JP5616889B2 (ja) 2014-10-29
IL210779A (en) 2015-07-30
EA201100229A1 (ru) 2011-08-30
ZA201100283B (en) 2011-10-26
UA100759C2 (uk) 2013-01-25
ME01494B (me) 2014-04-20
EP2151235A1 (de) 2010-02-10
DK2151235T3 (da) 2011-04-11
EP2306988A1 (de) 2011-04-13
US20140079646A1 (en) 2014-03-20

Similar Documents

Publication Publication Date Title
CY1113719T1 (el) Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερου πεπτικου σωληνα
HUS2100018I1 (hu) Hatóanyagok légúti beadására alkalmas készítmények és ezekkel kapcsolatos eljárások
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
IL255752B (en) Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer
LTC2137143I2 (lt) Pleuromutilino dariniai, skirti mikrobų sukeltų ligų gydymui
DK2010190T3 (da) Farmaceutisk opløsningsformulering til tryksatte, dosisregulerede inhalatorer
EA201300669A1 (ru) Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение
EP2399168A4 (en) CHEMICALLY REINFORCED RESISTANT COMPOSITION AND MOLDING PROCESS THEREFOR AND RESIST FILM THEREWITH
BRPI1007804A2 (pt) dosagem do filme de dissolução rápida por via oral, contendo esteviosídeos como um agente mascarador do sabor desagradável
EA201101190A1 (ru) Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение
MX2012001974A (es) Compuestos de biarilo y metodos de uso de los mismos.
EA201100335A1 (ru) Производные пурина для применения при лечении связанных с fab заболеваний
IT1402018B1 (it) Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
DK2462116T3 (da) Fremgangsmåde til fremstillingen af farmaceutisk aktive forbindelser
DOP2012000170A (es) Proceso para la fabricacion de un agente farmaceuticamante activo
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
DK2422786T3 (da) Nye lægemiddelkombinationer til behandling af luftvejssygdomme
WO2011072069A3 (en) Gastric retentive pharmaceutical compositions for extended release of polypeptides
EA201071209A1 (ru) Применение дронедарона или его фармацевтически приемлемой соли для получения лекарственного средства для регуляции уровня калия в крови
DK2101730T3 (da) Galenisk form til transmucosal indgivelse af paracetamol
DE502008002255D1 (de) Arzneimittel enthaltend Fraumenmantel zur Behandlung von Endometritis, Vaginitis
DK1856070T3 (da) Nye lægemidler til behandling af luftvejssygdomme
NO20090292L (no) Fenyleddiksyrederivater
DK2072041T3 (da) Fremgangsmåde til fremstilling af filmovertrukne tabletter, derindeholder drospirenon som aktivt stof
IT1390968B1 (it) Frazione glicolipidica di cianobatterio per il trattamento delle affezioni del cavo orale